Chemical Compound
NADPH tetracyclohexanamine
CAS Registry Number
100929-71-3
Primary Record
NADPH tetracyclohexanamine
- In stock
- 6,264 g
- Purity
- 99.8 %
- CAS
- 100929-71-3
Compound Identifiers & Properties
- CAS
- 100929-71-3
- PubChem CID
- 71312102
- SMILES
- C1CCC(CC1)N.C1CCC(CC1)N.C1CCC(CC1)N.C1CCC(CC1)N.C1C=CN(C=C1C(=O)N)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=NC5=C(N=CN=C54)N)OP(=O)(O)O)O)O)O
- Canonical SMILES
- NC(=O)C1=CN([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)[C@H](OP(=O)(O)O)[C@@H]3O)[C@@H](O)[C@H]2O)C=CC1.NC1CCCCC1.NC1CCCCC1.NC1CCCCC1.NC1CCCCC1
Names & Synonyms
- NADPH tetracyclohexanamine
- NADPH
- beta-NADPH
- 100929-71-3
- TPNH
- NADPH (tetracyclohexanamine)
- Beta-Nadph Tetra(Cyclohexylammonium) Salt
- NADPHtetracyclohexanamine
- |A-NADPH
- NADPH tetra(cyclohexammoninum)
- orb1307011
- NADPH tetrakis(cyclohexylamine)
- HY-F0003A
- DTXSID20746711
- PTKRUDMLGIIORX-ITGWJZMWSA-N
- C45H82N11O17P3
- MFCD00079504
- AKOS030526195
- ACN-036109
- CS-4997
- FN46723
- TETRAKIS(CYCLOHEXYLAMINE); NADPH
- Triphosphopyridine nucleotide, reduced form
- beta-NADPH tetra (cyclohexylammonium) salt
- F77994
- A925393
- [[(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate;cyclohexanamine
- BRD-M06409173-001-01-9
- B-NICOTINAMIDE ADENINE DINUCLEOTIDE*PHOS PHATE REDUC
- beta-NADPH, NADPH, TPNH, Triphosphopyridine nucleotide, reduced form
- |A-Nicotinamide adenine dinucleotide phosphate, reduced tetra(cyclohexylammonium) salt
- b-Nicotinamide adenine dinucleotide phosphate, reduced tetra(cyclohexylammonium)
- beta -Nicotinamide adenine dinucleotide phosphate, reduced tetra(cyclohexylammonium) salt
- beta-Nicotinamide adenine dinucleotide phosphate, reduced tetra(cyclohexylammonium) salt
- [(2R,3R,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3-hydroxy-4-(phosphonooxy)oxolan-2-yl]methyl [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1(4H)-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen diphosphate--cyclohexanamine (1/4)
- [[(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxy-tetrahydrofuran-2-yl]methoxy-hydroxy-phosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl hydrogen phosphate;cyclohexanamine
- 53-57-6
- Adenosine 5'-(trihydrogen diphosphate), 2'-(dihydrogen phosphate), P' inverted exclamation marku5'-ester with 1,4-dihydro-1-|_-D-ribofuranosyl-3-pyridinecarboxamide, compd. with cyclohexanamine (1:4)
- beta-Nicotinamide adenine dinucleotide phosphate, reduced tetra(cyclohexylammonium) salt, >=95%